Li Kang Biomedical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 12.21%

Li Kang Biomedical Co Ltd (6242) has an Asset Resilience Ratio of 12.21% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Li Kang Biomedical Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

NT$141.28 Million

≈ $4.45 Million USD Cash + Short-term Investments

Total Assets

NT$1.16 Billion

≈ $36.45 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2024)

This chart shows how Li Kang Biomedical Co Ltd's Asset Resilience Ratio has changed over time. See what is Li Kang Biomedical Co Ltd's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Li Kang Biomedical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Li Kang Biomedical Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$141.28 Million	12.21%
Total Liquid Assets	NT$141.28 Million	12.21%

Asset Resilience Insights

Moderate Liquidity: Li Kang Biomedical Co Ltd has 12.21% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Li Kang Biomedical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Li Kang Biomedical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Net Holding AS IS:NTHOL	Travel Services	0.00%
Voyageurs du Monde SA PA:ALVDM	Travel Services	13.68%
CVC Brasil Operadora e Agencia SA:CVCB3	Travel Services	5.26%
Societe Parisienne d’apports En Capital SPAC SA PA:MHM	Travel Services	3.85%
Corporate Travel Management Ltd AU:CTD	Travel Services	0.70%
Flight Centre Travel Group Ltd AU:FLT	Travel Services	0.41%
WEB Travel Group Ltd AU:WEB	Travel Services	30.69%
Helloworld Travel Ltd AU:HLO	Travel Services	10.12%

Annual Asset Resilience Ratio for Li Kang Biomedical Co Ltd (2002–2024)

The table below shows the annual Asset Resilience Ratio data for Li Kang Biomedical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	37.61%	NT$389.45 Million ≈ $12.27 Million	NT$1.04 Billion ≈ $32.63 Million	+14.73pp
2023-12-31	22.88%	NT$189.18 Million ≈ $5.96 Million	NT$827.00 Million ≈ $26.06 Million	+3.80pp
2022-12-31	19.08%	NT$131.42 Million ≈ $4.14 Million	NT$688.84 Million ≈ $21.70 Million	+7.00pp
2021-12-31	12.08%	NT$74.39 Million ≈ $2.34 Million	NT$616.07 Million ≈ $19.41 Million	-6.92pp
2020-12-31	19.00%	NT$122.50 Million ≈ $3.86 Million	NT$644.77 Million ≈ $20.31 Million	+10.72pp
2019-12-31	8.28%	NT$51.84 Million ≈ $1.63 Million	NT$626.44 Million ≈ $19.74 Million	+3.71pp
2013-12-31	4.56%	NT$5.10 Million ≈ $160.68K	NT$111.79 Million ≈ $3.52 Million	+2.13pp
2009-12-31	2.43%	NT$6.15 Million ≈ $193.76K	NT$252.83 Million ≈ $7.97 Million	-1.75pp
2008-12-31	4.18%	NT$18.34 Million ≈ $577.78K	NT$438.89 Million ≈ $13.83 Million	+2.75pp
2007-12-31	1.43%	NT$10.01 Million ≈ $315.37K	NT$701.86 Million ≈ $22.11 Million	-0.50pp
2006-12-31	1.92%	NT$14.56 Million ≈ $458.66K	NT$757.63 Million ≈ $23.87 Million	-0.42pp
2005-12-31	2.34%	NT$18.54 Million ≈ $584.17K	NT$791.11 Million ≈ $24.92 Million	-0.01pp
2004-12-31	2.35%	NT$18.05 Million ≈ $568.55K	NT$766.35 Million ≈ $24.14 Million	-0.48pp
2003-12-31	2.83%	NT$21.82 Million ≈ $687.48K	NT$770.15 Million ≈ $24.26 Million	+1.37pp
2002-12-31	1.47%	NT$11.24 Million ≈ $354.00K	NT$765.96 Million ≈ $24.13 Million	--

pp = percentage points

About Li Kang Biomedical Co Ltd

TWO:6242 Taiwan Travel Services

Market Cap

$38.53 Million

NT$1.22 Billion TWD

Market Cap Rank

#22817 Global

#1431 in Taiwan

Share Price

NT$38.45

Change (1 day)

-0.13%

52-Week Range

NT$37.25 - NT$44.15

All Time High

NT$13364.93